Archive for the ‘doing the right thing’ Category
“We retract this article to avoid misleading readers and intend to undertake further tests to confirm our previous results,” they write in the notice.
The scientists are working on developing a chip that uses resistive random-access memory, which allows a huge amount of information to be stored in a tiny package and accessed quickly while using very little power. A number of companies are working on the technology, but none have successfully commercialized it.
The “worst moment of my scientific career:” Two bird migration articles brought down by analytical error
Evolutionary and conservation biologists in Spain are retracting two articles – one from the Journal of Avian Biology and the other from Ardeola – because they discovered a fatal flaw in their analysis.
The Journal of Avian Biology article, “Are European birds leaving traditional wintering grounds in the Mediterranean?” aimed to determine whether the abundance of passerines had decreased in recent decades, but failed to control for birds that may have gotten killed by hunters. Although it was published in January, we can only find an abstract from its acceptance by the journal in November 2014.
Although they are confident that the strategy is sound, the authors write in their commendably detailed retraction notice that the “inadvertent error” rendered the results “uninterpretable.”
High blood levels of PFOA have been tied to kidney disease in humans, as well as several cancers in animal models. The majority of the U.S. Environmental Protection Agency’s scientific advisory board deemed PFOA “likely to be carcinogenic in humans” in 2006, though a decade later the EPA has yet to make a decision on regulations. The retracted paper found that exposing pregnant mice to PFOA altered hormone pathways in mammary glands.
According to the notice in Toxicological Sciences, there was a duplicated image in one of the figures, as well as “some minor errors.” Here’s figure 5B: Read the rest of this entry »
Chemists at Lanzhou University in China did the right thing last month, retracting a paper in Advanced Synthesis & Catalysis because of issues with a reactant that could only be corrected by changing “all the text and quantities.”
When the scientists were adding what was labeled Reactant 1 to the mix, they believed it was α-ethoxycarbonyl-α-azido-N-phenylacetamides. Unfortunately, what they were actually using was a decomposed version of the molecule, which threw everything off.
A paper whose expression of concern we covered in November 2014 has been retracted and republished “because of the extent of the changes necessary,” according to the Lancet Respiratory Medicine.
This study was a meta-analysis of research on how the timing of tracheostomies — placing a breathing tube directly into the windpipe — affects patients’ mortality rate. The original paper found that critically ill patients who received a tracheostomy earlier fared better than those for whom the procedure was delayed for weeks after intubation, the recommended practice.
However, when the authors calculated how many patients died, they assumed that any patient who wasn’t discharged from the intensive care unit (ICU) had died there, instead of looking for other explanations. This made their estimates unreliable.
The publisher convened a panel, which ultimately decided retraction and republication was the most appropriate course of action.
The authors of a 2014 paper in The Scientific World Journal on rock slopes have retracted their article for “erroneous” data.
The paper, “Slope Stability Analysis Using Limit Equilibrium Method in Nonlinear Criterion,” came from a group of researchers from institutions including the Changjiang River Scientific Research Institute in Wuhan, and the Key Laboratory of Transportation Tunnel Engineering at Southwest Jiaotong University in Chengdu. It’s about (we think) how to calculate the safety of rock slopes, and how vulnerable they are to landslides.
Here’s the notice, which as a pretty fair ratio of words to information:
A group of researchers in China and the United States have retracted a 2014 paper in the Journal of Cardiovascular Pharmacology after discovering the data were fatally flawed.
The article examined whether the anti-arrhythmia drug zacopride affected cardiac remodeling after heart attack, and came from Bo-We Wu, of Shanxi Medical University, in Taiyuan, and colleagues, including one author from Savannah, Georgia.
Here’s more from the notice for “Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction”:
Prominent plant researcher Mark Estelle has retracted a paper on plant hormones after follow-up studies showed the conclusions were incorrect.
The hormone in question, auxin, is a major player in plant growth and development. The retracted Current Biology paper reported that a certain auxin receptor, designated AFB4, downregulates the responses of cabbage-cousin Arabidopsis thaliana to the signaling molecule. But after publication, the researchers experimented with a mutant seedling that didn’t produce the receptor, and discovered it didn’t overreact to auxin signals, indicating the receptor wasn’t playing a major role in limiting the effects.
Estelle, a Howard Hughes Medical Institute investigator based at the University of California, San Diego, told us he and his team are working on a paper that will contain the accurate data from the paper, along with new findings.
According to last author Rory Waterman at the University of Vermont, an undetected reaction caused his lab to mistakenly mischaracterize the products of an iridium catalyst. The diligence of a graduate student brought it all to light, he noted: “In short, it was the ability of one of my group members to be a very good scientist.”
The letter, titled “High Activity and Selectivity for Silane Dehydrocoupling by an Iridium Catalyst,” was published in February. It has only accumulated 5 citations, according to Thomson Scientific’s Web of Knowledge.